Cargando…

Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis

BACKGROUND AND OBJECTIVE: Characterizing nicotine pharmacokinetics is challenging in the presence of background exposure. We performed a combined retrospective population pharmacokinetic analysis of 8 trials, including exposure to Tobacco Heating System and cigarettes (both inhaled), nicotine nasal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchand, Mathilde, Brossard, Patrick, Merdjan, Henri, Lama, Nicola, Weitkunat, Rolf, Lüdicke, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681983/ https://www.ncbi.nlm.nih.gov/pubmed/28283988 http://dx.doi.org/10.1007/s13318-017-0405-2

Ejemplares similares

Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes
por: Picavet, Patrick, et al.
Publicado: (2016)

A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers
por: Lüdicke, Frank, et al.
Publicado: (2015)

Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System
por: Teichert, Axel, et al.
Publicado: (2018)

Evaluation of Biomarkers of Exposure in Smokers Switching to a Carbon-Heated Tobacco Product: A Controlled, Randomized, Open-Label 5-Day Exposure Study
por: Lüdicke, Frank, et al.
Publicado: (2016)

Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2)
por: Lüdicke, Frank, et al.
Publicado: (2018)

Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1)
por: Lüdicke, Frank, et al.
Publicado: (2018)

Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
por: Olsson Gisleskog, Per O., et al.
Publicado: (2020)

Development and validation of a new instrument to measure perceived risks associated with the use of tobacco and nicotine-containing products
por: Cano, Stefan, et al.
Publicado: (2018)

Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020
por: Sponsiello-Wang, Zheng, et al.
Publicado: (2019)

Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1
por: Lüdicke, Frank, et al.
Publicado: (2017)

Biological and Functional Changes in Healthy Adult Smokers Who Are Continuously Abstinent From Smoking for One Year: Protocol for a Prospective, Observational, Multicenter Cohort Study
por: Tran, Cam Tuan, et al.
Publicado: (2019)

Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)
por: Haziza, Christelle, et al.
Publicado: (2019)

Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
por: Rasmussen, Scott, et al.
Publicado: (2018)

Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1)
por: Haziza, Christelle, et al.
Publicado: (2019)

Evaluation of Biological and Functional Changes in Healthy Smokers Switching to the Tobacco Heating System 2.2 Versus Continued Tobacco Smoking: Protocol for a Randomized, Controlled, Multicenter Study
por: Ansari, S Michael, et al.
Publicado: (2018)

Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product into the U.S. Market
por: Djurdjevic, Smilja, et al.
Publicado: (2018)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019)

Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013)

Potential predictors of adoption of the Tobacco Heating System by U.S. adult smokers: An actual use study
por: Roulet, Steve, et al.
Publicado: (2021)

Addiction to the nicotine gum in never smokers
por: Etter, Jean-François
Publicado: (2007)

Behavioral Outcomes of Nicotine Reduction in Current Adult Smokers
por: Smith, Tracy T, et al.
Publicado: (2019)

Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses
por: Bilal, Rabiea, et al.
Publicado: (2022)

An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers
por: Goldenson, Nicholas I, et al.
Publicado: (2021)

Socioeconomic differences in nicotine exposure and dependence in adult daily smokers
por: Chen, Allshine, et al.
Publicado: (2019)

Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers
por: Perez-Paramo, Yadira X., et al.
Publicado: (2023)

Prevalence of NRT Use and Associated Nicotine Intake in Smokers, Recent Ex-Smokers and Longer-Term Ex-Smokers
por: Shahab, Lion, et al.
Publicado: (2014)

Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers
por: Keyser, Brian M., et al.
Publicado: (2023)

Population pharmacokinetics and exposure–response analyses of varenicline in adolescent smokers
por: Fediuk, Daryl J., et al.
Publicado: (2021)

Nicotine Dependence, Physical Activity, and Sedentary Behavior among Adult Smokers
por: Loprinzi, Paul D., et al.
Publicado: (2015)

Predictors of Nicotine Dependence Among Adult Male Midwakh and Cigarette Smokers
por: Al Sharbatti, Shatha, et al.
Publicado: (2022)

Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers
por: Kuwabara, Hiroto, et al.
Publicado: (2014)

Are healthy smokers really healthy?
por: Zhou, Zijing, et al.
Publicado: (2016)

Dopamine genes and nicotine dependence in treatment seeking and community smokers
por: Bergen, Andrew W., et al.
Publicado: (2009)

The Relationship between Nicotine Dependence and Age among Current Smokers
por: LI, Huijie, et al.
Publicado: (2015)

Associations of clinical, psychological, and socioeconomic characteristics with nicotine dependence in smokers
por: Sim, Yun Su, et al.
Publicado: (2021)

Paper-Based Potentiometric Sensors for Nicotine Determination in Smokers’ Sweat
por: Amr, Abd El-Galil E., et al.
Publicado: (2021)

Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers
por: Borrego‐Soto, Gissela, et al.
Publicado: (2023)

Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days
por: Haziza, Christelle, et al.
Publicado: (2016)

Do nicotine dependence influencing and non-influencing behaviors have an association with high nicotine dependence in smokers?
por: Chen, Zhongbo, et al.
Publicado: (2021)

“Push it!” or “Hold it!”? A comparison of nicotine-avoidance training and nicotine-inhibition training in smokers motivated to quit
por: Machulska, Alla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8skm60n07svves8sd7ee5gfv5p